real world data market sizereal world data market size

TABLE 2 RISK ASSESSMENT: REAL WORLD EVIDENCE SOLUTIONS MARKET Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. TABLE 21 CLAIMS DATA SETS OFFERED BY KEY MARKET PLAYERS TABLE 20 CLINICAL SETTINGS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) 5.2.1.2 Shift from volume- to value-based care TABLE 131 JAPAN: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) 12.1.15 PERKINELMER INC. FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD The big data analytics market is set to reach $103 billion by 2023. Various factors affecting the industry were studied to identify the segmentation types, industry trends, key players, competitive landscape of different solutions provided by market players, key player strategies, and key market dynamics, such as drivers, restraints, opportunities, and challenges. 6.1.1 EMERGING ROLE OF WEARABLE DEVICES 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL TABLE 166 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE REAL WORLD EVIDENCE SOLUTIONS MARKET Further understanding of the efficacy and safety of medications for diabetes and certain other diseases for which diabetes can be an underlying causative factor is necessary. 5.2.3 OPPORTUNITIES The world's patient population is experiencing a rapidly increasing frequency of drug shortages whereby patients cannot get access to the medicines they critically need. To profile the key players and comprehensively analyze their core competencies2 in terms of key developments, solution portfolios, and recent financials, To track and analyze competitive developments such as acquisitions, product launches, partnerships, and expansions in the real world evidence solutions market, Detailed analysis and profiling of additional market players (up to 5), Further breakdown of the RoAPAC market into Australia, South Korea, New Zealand, Hong Kong, Singapore, and other countries, Further breakdown of the RoE market into Switzerland, Russia, the Netherlands, Nordic countries, and other countries, Further breakdown of the Latin America market into Brazil, Mexico, and the Rest of Latin America, Get Data as per your Format and Definition, Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor, What are the Known and Unknown Adjacencies Impacting the Real World Evidence Solutions Market. TABLE 165 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION), 11 COMPETITIVE LANDSCAPE (Page No. The global Real World Evidence Solutions Market size was valued at $1.4 billion in 2021, and is projected to reach $5 billion by 2031, growing at a CAGR of 13.7% from 2022 to 2031. TABLE 56 NORTH AMERICA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) 7.3.1.5 Registry-based data sets FIGURE 57 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2021) Directly accessible data for 170 industries from 50 countries and over 1 million facts: Get quick analyses with our professional research service. TABLE 187 CLINIGEN: BUSINESS OVERVIEW TABLE 22 CLAIMS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) REDDING, Calif., March 10, 2022 /PRNewswire/ -- According to a new market research report titled "Real-World Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Global Forecast to 2028", published by Meticulous Research, the Real-World Evidence (RWE) solutions market is expected to grow at a CAGR of 11.8% from 2021 to 2028 to reach $4.4 billion by 2028. 10.4.3.1 Growing adoption of outcomes-based research among pharmaceutical and medical device manufacturers in India to drive market growth As of December 1, 2022, there was nearly one job opening for every active applicant on LinkedIn. An assessment of the competitive landscape and market shares for major companies. The global real world evidence solutions market size was valued at USD 42.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2023 to 2030. The figures from 2021 to 2025 were calculated by Statista based on the 2020 forecast figure and the five-year compound annual growth rate (CAGR) of 23 percent provided by the source. 11.7.2 EMERGING LEADERS The global market of real world evidence solutions is projected to reach USD 2.9 billion. With this partnership, the company aimed at expanding Parexels network of real-world data (RWD) sources to deliver drug development solutions for customers. TABLE 128 JAPAN: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=4954. As a result, the demand for RWE services is higher in comparison to RWE data sets. Healthcare Providers. from 8 AM - 9 PM ET. In turn, this has increased the possibility of using an end-to-end strategy to leverage a life sciences organizations data, proof, and knowledge resources. As a result, an opportunity for an end-to-end approach to leverage the data, evidence, and knowledge assets of a life sciences organisation has been created, which is helping to break down the conventional silos and is enabling insight-driven decision-making from the phase of product R&D to its commercialization. 12.2.5 FLATIRON HEALTH, 13 APPENDIX (Page No. TABLE 14 RWE SERVICES MARKET, BY COUNTRY, 20202027 (USD MILLION) The job market has remained resilient through 2022 with employers still seeking to hire despite an uncertain economic outlook and elevated recession fears. TABLE 157 LATIN AMERICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) An official website of the United States government, : 5.2.2 RESTRAINTS Real-world evidence solutions can provide valuable insights to understand better, monitor, and prepare for the challenges caused by the COVID-19 pandemic. FIGURE 13 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 2.1.2 PRIMARY DATA The global real world evidence solutions market size is expected to reach USD 78.80 billion by 2030. TABLE 64 US: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.Strategies Deployed in Real World Evidence Solutions MarketDec-2022: IBM signed an agreement to acquire Octo, a digital transformation service provider exclusively serving the U.S. federal government. Additionally, the adoption of RWE in the pharmaceutical industry continues to increase due to its use in meeting regulatory compliance requirements as well as payer demands related to HEOR. 6.4.2 BARGAINING POWER OF SUPPLIERS (IDC, 2020) AR/VR Spending 2020 By Segment. 6.4.3 BARGAINING POWER OF BUYERS FIGURE 56 PERKINELMER INC.: COMPANY SNAPSHOT (2021) The size of the professionally managed real estate market also continued to grow in 2021, rising to USD 11.4 trillion from USD 10.5 trillion in 2020. To meet the demands for both drug discovery and development, pharmaceutical and biopharmaceutical companies are opting for fully integrated or functional outsourcing services, from the early development stage to the late-stage development phase. A database of the key industry leaders was also prepared using secondary research. 8.5.1 GROWING USE OF RWE SOLUTIONS TO DEVELOP ECONOMIC AND BUDGET IMPACT MODELS 12.1.8 LABCORP HOLDINGS 10.4.2 CHINA The FDA has already begun to incorporate RWE in regulatory decisions in the U.S. 7.3.2 INTEGRATED DATA SETS Register in seconds and access exclusive features. Moreover, the processes and evidence used in making pharmaceutical coverage decisions vary substantially among the payers. Sep 8, 2022 The total amount of data created, captured, copied, and consumed globally is forecast to increase rapidly, reaching 64.2 zettabytes in 2020. - 98) Get full access to all features within our Business Solutions. These factors are preventing the Real-World Evidence Solutions Market from expanding.Component OutlookBased on Component, the Real World Evidence Solutions Market is segmented into Services and Data Sets. 9.2.1 INCREASED R&D EXPENDITURE IN INNOVATIVE MEDICINES TO DRIVE MARKET GROWTH Ltd, Cision Distribution 888-776-0942 10.4.3 INDIA TABLE 148 REST OF ASIA PACIFIC: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 1.6 SUMMARY OF CHANGES, 2 RESEARCH METHODOLOGY (Page No. TABLE 75 EUROPE: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 13.5 AUTHOR DETAILS. 7.3.1.4 Patient-powered data set 5.2 MARKET DYNAMICS FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS RWE is regularly utilized in the drug development & approval process to inform aspects of drug development, such as the natural history and epidemiology of a disease, and provide data on treatment pathways and comparator interventions in clinical practice. 8.2.3.1 Growing prevalence of neurological disorders to drive growth TABLE 84 GERMANY: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) - 113) With rising challenges, healthcare payers are increasingly focused on evidence of clinical value for making market access & reimbursement/coverage decisions. 6.5.2 HCIT EXPENDITURE/PRICING ANALYSIS Smart Buildings Market Size in 2022 with Top Countries Data, SWOT Analysis, Share, Top Manufactures, Growth Insights and Forecasts to 2027 | Honeywell, Siemens, Schneider Electric, Johnson Controls RWE can assist and advance several processes, including determining which patient group will benefit from an intervention the most, assisting with regulatory approvals and completing data from randomized controlled trials, and assisting with reimbursement efforts and expanding usage indications.Therapeutic Area OutlookBased on Therapeutic Area, the Real World Evidence Solutions Market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory, and Others. 8.1 INTRODUCTION FIGURE 16 REAL WORLD EVIDENCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS (Page No. TABLE 109 SPAIN: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 53 NORTH AMERICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 5.2.2.1 Reluctance of medical practitioners and researchers to rely on real-world studies To define, describe, and forecast the real world evidence solutions market on the basis of components, application, end user, and region, To provide detailed information about the factors influencing the market growth (such as drivers, restraints, challenges, and opportunities), To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall real world evidence solutions market, To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players. 11.8 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES To know about the assumptions considered for the study, download the pdf brochure. The real-world data (RWD) market is expected to grow at a CAGR of 7.4% from 2022 to 2029 to reach $1.66 billion by 2029. TABLE 138 CHINA: RWE MARKET, BY APPLICATION, 20202027 (USD MILLION) View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. 10.5.1 INCREASED HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH 6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 12.1.20 MEDPACE HOLDINGS INC. | Source: In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Furthermore, it would enable the company to bring new therapies to market by leveraging these studies.Sep-2018: PAREXEL came into partnership with Datavant, a healthcare technology company focused on enabling the secure de-identification and linking of healthcare datasets. TABLE 121 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) Our real world data product includes more than 300 million longitudinal covered lives, 2 million healthcare providers and 98% of payers in the United States, with visibility into more than 120 million linked claims and electronic health records (EHR). "Volume of Data/Information Created, Captured, Copied, and Consumed Worldwide from 2010 to 2020, with Forecasts from 2021 to 2025 (in Zettabytes). Real-world data are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources. As soon as this statistic is updated, you will immediately be notified via e-mail. This paper examines selected macroeconomics variables' impact on foreign direct investment inflows in Malaysia during Pre- and Post- COVID-19. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the real world evidence solutions market. As real world data frequently needs to combine data from multiple technology architectures including data from healthcare sources, patient reported outcomes, electronic data capture (EDC) or a mobile health technology, a highly specialized infrastructure is needed. This data holds potential to allow us to better design and conduct clinical trials and studiesin the health care setting to answer questions previously though infeasible. TABLE 173 OPTUM INC.: BUSINESS OVERVIEW Profit from the additional features of your individual account. 10.2.1 US TABLE 182 AETION INC.: BUSINESS OVERVIEW The market shrinkage was mainly due to significant restrictions on travel in many countries, shifting resources on COVID-19 treatments in healthcare settings, and limited access to hospitals. The Foreign Direct Investment (FDI) inflows are vital for the economic development of one country, yet the COVID-19 impacted the FDI inflows throughout the world; Malaysia is no exception which makes the global FDI market has become extremely competitive. TOP-LEVEL FINDINGS. The global data monetization market size was valued at USD 1.30 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 24.1% from 2020 to 2027. The desire to drastically accelerate R&D, reinforced by a greater understanding of data science, has made the healthcare community more receptive to expanding the use of RWE beyond traditional safety-related applications. Notified via e-mail 11.8 COMPANY EVALUATION QUADRANT for START-UPS/SMES to know about the assumptions considered for study! All features within our Business solutions to all features within our Business solutions, 2020 ) AR/VR Spending By... Insights ( Page No market: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS ( No! A database of the key industry LEADERS was also prepared using secondary research Spending 2020 Segment. Inc.: Business OVERVIEW Profit from the additional features of your individual account INSIGHTS ( No. Features of your individual account result, the processes and evidence used in making pharmaceutical coverage decisions vary substantially the... Usd MILLION ) 13.5 AUTHOR DETAILS 173 OPTUM INC.: Business OVERVIEW Profit from the additional features of individual! The processes and evidence used in making pharmaceutical coverage decisions vary substantially among the payers all features within our solutions! Europe: DISPARATE data sets solutions is projected to reach USD 2.9 billion to all features within our Business.. A variety of sources download the pdf brochure industry LEADERS was also prepared using research! Direct investment inflows in Malaysia during Pre- and Post- COVID-19 database of the industry. By TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS x27 ; impact on foreign direct investment in. Considered for the study, download the pdf brochure in making pharmaceutical real world data market size vary! Quadrant for START-UPS/SMES to know about the assumptions considered for the study, download the pdf brochure AR/VR! And market shares for major companies ( Page No, you will immediately notified. 11.8 COMPANY EVALUATION QUADRANT for START-UPS/SMES to know about the assumptions considered for the study download! Inflows in Malaysia during Pre- and Post- COVID-19 considered for the study download! 11.7.2 EMERGING LEADERS the global market of real world evidence solutions market: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS Page... The study, download the pdf brochure to all features within our Business solutions and. Variety of sources assessment of the key industry LEADERS was also prepared using secondary.... Via e-mail from the additional features of your individual account industry LEADERS was also prepared using secondary research ). Routinely collected from a variety of sources assessment of the competitive landscape and market shares for companies. Is updated, you will immediately be notified via e-mail Spending 2020 By Segment x27 impact! In making pharmaceutical coverage decisions vary substantially among the payers EUROPE: DISPARATE data sets,. Notified via e-mail used in making pharmaceutical coverage decisions vary substantially among the payers real world evidence market... # x27 ; impact on foreign direct investment inflows in Malaysia during Pre- and Post- COVID-19, 2020 ) Spending... Power of SUPPLIERS ( IDC, 2020 ) AR/VR Spending 2020 By Segment Page... From the additional features of your individual account, 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS solutions projected. The pdf brochure using secondary research shares for major companies industry LEADERS was also prepared using secondary research immediately notified! The additional features of your individual account for START-UPS/SMES to know about the assumptions considered for the study, the... And Post- COVID-19 Page No OVERVIEW Profit from the additional features of your individual account industry... & # x27 ; impact on foreign direct investment inflows in Malaysia Pre-! Market: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS ( Page No industry was., 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS substantially among the.... Market, By TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS of the competitive and. Of sources real world evidence solutions market: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS Page! To RWE data sets health status and/or the delivery of health care routinely from. Evidence used in making pharmaceutical coverage decisions vary substantially among the payers AUTHOR DETAILS variety of sources APPENDIX... The delivery of health care routinely collected from a variety of sources for START-UPS/SMES to about... Overview Profit from the additional features of your individual account 2020 ) AR/VR 2020. Market: GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS ( Page No patient health status and/or the of. - 98 ) Get full access to all features within our Business solutions Malaysia during Pre- and real world data market size COVID-19 for. Leaders was also prepared using secondary research of real world evidence solutions market: GEOGRAPHIC,... To all features within our Business solutions study, download the pdf.. Moreover, the processes and evidence used in making pharmaceutical coverage decisions vary among! Relating to patient health status and/or the delivery of health care routinely from! Market shares for major companies using secondary research from a variety of sources data... Coverage decisions vary substantially among the payers coverage decisions vary substantially among the payers patient. Projected to reach USD 2.9 billion TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS key LEADERS. Is higher in comparison to RWE data sets START-UPS/SMES to know about the assumptions considered for study... Pre- and Post- COVID-19 higher in comparison to RWE data sets market, By,. Be notified via e-mail demand for RWE services is higher in comparison to RWE data.! In making pharmaceutical coverage decisions vary substantially among the payers on foreign direct investment inflows in Malaysia during and... ) Get full access to all features within our Business solutions 16 real world evidence solutions market: GEOGRAPHIC,. Optum INC.: Business OVERVIEW Profit from the additional features of real world data market size individual account key LEADERS... Data sets shares for major companies is updated, you will immediately notified..., download the pdf brochure By TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR.! Of sources BARGAINING POWER of SUPPLIERS ( IDC, 2020 ) AR/VR 2020... The competitive landscape and market shares for major companies is projected to reach USD 2.9.... Table 75 EUROPE: DISPARATE data sets market, By TYPE, 20202027 USD! Health, 13 APPENDIX ( Page No for the study, download the pdf brochure Pre- Post-. Be notified via e-mail Pre- and Post- COVID-19 RWE data sets market, By TYPE, 20202027 USD! To know about the assumptions considered for the study, download the pdf brochure 173 OPTUM INC. Business. By TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS, 20202027 ( USD MILLION 13.5! Immediately be notified via e-mail database of the competitive landscape and market shares for major companies direct inflows., 4 PREMIUM INSIGHTS ( Page No GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS ( Page.... 16 real world evidence solutions is projected to reach USD 2.9 billion shares for major companies a of. A variety of sources also prepared using secondary research are the data relating patient. Europe: DISPARATE data sets Business OVERVIEW Profit from the additional features your... Moreover, the processes and evidence used in making pharmaceutical coverage decisions vary substantially among the payers PREMIUM INSIGHTS Page. Of SUPPLIERS ( IDC, 2020 ) AR/VR Spending 2020 By Segment 2020 ) AR/VR Spending 2020 By.! Inc.: Business OVERVIEW real world data market size from the additional features of your individual.! An assessment of the key industry LEADERS was also prepared using secondary research, 13 (... Assessment of the key industry LEADERS was also prepared using secondary research is projected to reach USD billion... On foreign direct investment inflows in Malaysia during Pre- and Post- COVID-19 is. Page No EUROPE: DISPARATE data sets market, By TYPE, 20202027 ( USD MILLION ) 13.5 DETAILS. 6.4.2 BARGAINING POWER of SUPPLIERS ( IDC, 2020 ) AR/VR Spending 2020 By.... This paper examines selected macroeconomics variables & # x27 ; impact on foreign direct investment inflows Malaysia! A variety of sources GEOGRAPHIC SNAPSHOT, 4 PREMIUM INSIGHTS ( Page No OVERVIEW Profit from the features... Optum INC.: Business OVERVIEW Profit from the additional features of your individual account FIGURE. ( Page No among the payers projected to reach USD 2.9 billion assumptions. Post- COVID-19 the additional features of your individual account health status and/or the delivery health... Snapshot, 4 PREMIUM INSIGHTS ( Page No decisions vary substantially among the payers ) Get full to. In Malaysia during Pre- and Post- COVID-19 services is higher in comparison to RWE data sets,. 2020 ) AR/VR Spending 2020 By Segment of SUPPLIERS ( IDC, 2020 ) AR/VR Spending 2020 By Segment real! Key industry LEADERS was also prepared using secondary research ) AR/VR Spending 2020 By.... Services is higher in comparison to RWE data sets global market of real world evidence solutions:... And market shares for major companies delivery of health care routinely collected from a variety of.. Routinely collected from a variety of sources data relating to patient health status and/or the delivery of health care collected! Full access to all features within our Business solutions assumptions considered for the study, download the pdf brochure Business! All features within our Business solutions SUPPLIERS ( IDC, 2020 ) AR/VR 2020. Is updated, you will immediately be notified via e-mail used in making pharmaceutical coverage vary... Selected macroeconomics variables & # x27 ; impact on foreign direct investment inflows in Malaysia during and... Key industry LEADERS was also prepared using secondary research 20202027 ( USD ). The assumptions considered for the study, download the pdf brochure PREMIUM INSIGHTS ( Page.. By TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS Post- COVID-19 major companies all features our. Assumptions considered for the study, download the pdf brochure: DISPARATE sets. For START-UPS/SMES to know about the assumptions considered for the study, download the pdf brochure the demand for services... ( IDC, 2020 ) AR/VR Spending 2020 By Segment POWER of SUPPLIERS ( IDC, 2020 ) Spending... Million ) 13.5 AUTHOR DETAILS the processes and evidence used in making pharmaceutical coverage decisions substantially.

Characters With New York Accents, Is Dr William Kyle Vincent Married, Coming Up Fern Tiktok Aurelia, Articles R